Order a call

Contraceptives and vein diseases


Hormonal contraception and vein diseases.


Oral contraceptives are one of the achievements of medicine in recent decades. Women use them as an effective method of contraception or to treat various gynecological diseases. Combined oral contraceptives (COCs) have a significant number of contraindications, and They are used only as prescribed by a doctor. We are always up to date with the latest recommendations on the use of hormonal contraception, because the main side effects relate to the cardiovascular system. The fifth edition of the WHO "Medical eligibility criteria for contraceptive use", published in 2015, refers to evidence-based medicine and analyzes hundreds of scientific publications. We are happy to share information.



  • COC use increases the risk of venous thromboembolism about 3 to 5 times data from various publications. In the presence of hereditary thrombophilia before, this figure may be higher. Therefore, women with a family history of venous thrombosis and confirmed factor II, V mutations or protein S, C, antithrombin III deficiencies and antiphospholipid syndrome should not use these drugs for contraception.
  • The next absolute contraindication is repeated deep vein thrombosis or pulmonary embolism or acute period of these diseases (up to 3 months from the date of diagnosis). The appointment of hormonal drugs can cause re-thrombosis.
  • Varicosis of the lower extremities DOES NOT LIMIT the use of any method of contraception. In addition, even with varicothrombophlebitis, the use of these drugs can be continued when the benefits of them are greater than the risks. In such situations, the joint decision of the gynecologist and phlebologist.
  • is better
  • To prevent venous thrombosis, it is better to stop hormone therapy at least a month before a major surgery if it is associated with prolonged bed rest.



  • For women over 35 who smoke, it is best not to use COCs as a contraceptive method due to the risk of complications.
  • Impaired lipid metabolism, severe arterial hypertension (160 mm Hg) and complications of diabetes are the main risk factors.


This information only applies to COCs as they contain a high dose of estrogen and have a negative effect on the blood clotting system.

Most thrombosis occurs within the first 12 months of therapy. After that, the risk is greatly reduced. In our practice, there are often situations when patients with contraindications, especially those with venous diseases, need hormone therapy due to gynecological problems. Such situations require the mandatory participation of a phlebologist and gynecologist to assess risks.


Come to us for quality advice according to world standards. We always have the most up-to-date data on vascular diseases.

Author: ©

Get a consultation
about services by phone
Has any questions?
Fill out the form and we will call you back!